Post-lesion Administration of Dexamethasone to Prevent the Development of Neuritis After Radiofrequency Ablation
| Status: | Recruiting |
|---|---|
| Healthy: | No |
| Age Range: | 18 - 90 |
| Updated: | 12/21/2018 |
| Start Date: | September 1, 2017 |
| End Date: | September 2019 |
| Contact: | Akhil Chhatre, MD |
| Email: | achhatr1@jhmi.edu |
| Phone: | (410) 614-4030 |
Chronic neck and back pain has become one of the leading causes of disability and loss of
productivity. For many patients with facet or sacroiliac joint mediated pain who have
responded to diagnostic nerve blocks, radiofrequency ablation of the nerves innervating the
joints can provide long term relief. Radiofrequency ablation (RFA) is a relatively safe
procedure with minimal risk of adverse events. However, with any procedure involving damage
to the peripheral nervous system, there is risk of post-procedure neuropathic pain. The
investigators will test the hypothesis that dexamethasone injection delivered at the time of
lesion effectively prevents the development of post-ablation neuritis through a
placebo-controlled, double-blind, randomized trial in patients undergoing cervical, thoracic,
lumbar, and sacroiliac joint radiofrequency denervations
productivity. For many patients with facet or sacroiliac joint mediated pain who have
responded to diagnostic nerve blocks, radiofrequency ablation of the nerves innervating the
joints can provide long term relief. Radiofrequency ablation (RFA) is a relatively safe
procedure with minimal risk of adverse events. However, with any procedure involving damage
to the peripheral nervous system, there is risk of post-procedure neuropathic pain. The
investigators will test the hypothesis that dexamethasone injection delivered at the time of
lesion effectively prevents the development of post-ablation neuritis through a
placebo-controlled, double-blind, randomized trial in patients undergoing cervical, thoracic,
lumbar, and sacroiliac joint radiofrequency denervations
Inclusion Criteria:
- patients with a diagnosis of either cervical, thoracic, or lumbar facet or sacroiliac
joint pain who have responded to medial branch blocks and are already scheduled for
bilateral radiofrequency ablations
- age greater than 18 years old
- English speaking
Exclusion Criteria:
- patient not previously scheduled for radiofrequency ablation of the cervical,
thoracic, or lumbar facets, or sacroiliac joints
- on anticoagulation
- have a pacemaker
- age less than 18 years old
- non-English speaking
We found this trial at
1
site
Johns Hopkins Hospital Patients are the focus of everything we do at The Johns Hopkins...
Click here to add this to my saved trials
